Stifel Maintains Buy on Outset Medical, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise has maintained a 'Buy' rating on Outset Medical (NASDAQ:OM) but lowered the price target from $26 to $6.

October 13, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's price target has been lowered from $26 to $6 by Stifel, though the 'Buy' rating is maintained.
The lowering of the price target by Stifel indicates a potential decrease in the stock's value. However, the maintained 'Buy' rating suggests that the stock is still expected to perform well in the long term. This could lead to short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100